Rahime Şimşek (Rahime Simsek)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Molecular Docking

Human Serum Albumin

Positron Emission Tomography

Top Venues

Acta crystallographica. Section E, Crystallographic communications

ACS pharmacology & translational science

Turkish journal of chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ezgi Pehlivanlar, Deniz Arca Çakır, Sonia Sanajou, Hülya Tezel Yalçin, Terken Baydar, Pinar Erkekoğlu, Hanife Avci, Rahime Şimşek
Synthesis and characterization of new hexahydroquinoline derivatives and evaluation of their cytotoxicity, intracellular ROS production, and inhibitory effects on inflammatory mediators. Turkish journal of chemistry 48 (4) (2024)
Ezgi Pehlivanlar, Simone Carradori, Rahime Şimşek
Migraine and Its Treatment from the Medicinal Chemistry Perspective. ACS pharmacology & translational science 7 (4) (2024)
Ezgi Pehlivanlar, Simone Carradori, Rahime Şimşek
Migraine and Its Treatment from the Medicinal Chemistry Perspective. ACS pharmacology & translational science 7 (4) (2024)
Ezgi Pehlivanlar, Simone Carradori, Rahime Şimşek
Migraine and Its Treatment from the Medicinal Chemistry Perspective. ACS pharmacology & translational science 7 (4) (2024)
Sema Öztürk Yıldırım, Mehmet Akkurt, Ezgi Pehlivanlar, Gökalp Çetin, Rahime Şimşek, Raymond John Butcher, Ajaya Bhattarai
Syntheses, characterizations, crystal structures and Hirshfeld surface analyses of methyl 4-[4-(di-fluorometh-oxy)phen-yl]-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate, isopropyl 4-[4-(di-fluoro-meth-oxy)phen-yl]-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate and tert -butyl 4-[4-(di-fluoro-meth-oxy)phen-yl]-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate. Acta crystallographica. Section E, Crystallographic communications 80 (Pt 3) (2024)
Sema Öztürk Yıldırım, Mehmet Akkurt, Ezgi Pehlivanlar, Gökalp Çetin, Rahime Şimşek, Raymond John Butcher, Ajaya Bhattarai
Syntheses, characterizations, crystal structures and Hirshfeld surface analyses of methyl 4-[4-(di-fluorometh-oxy)phen-yl]-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate, isopropyl 4-[4-(di-fluoro-meth-oxy)phen-yl]-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate and tert -butyl 4-[4-(di-fluoro-meth-oxy)phen-yl]-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate. Acta crystallographica. Section E, Crystallographic communications 80 (Pt 3) (2024)
Muhammad Babar Taj, Ahmad Raheel, Rabia Ayub, Afnan M Alnajeebi, Matokah Abualnaja, Alaa Hamed Habib, Walla Alelwani, Sadia Noor, Sami Ullah, Abdullah G Al-Sehemi, Rahime Şimşek, Nouf Abubakr Babteen, Heba Alshater
Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations. PloS one 18 (2) (2023)
Muhammad Babar Taj, Ahmad Raheel, Rabia Ayub, Afnan M Alnajeebi, Matokah Abualnaja, Alaa Hamed Habib, Walla Alelwani, Sadia Noor, Sami Ullah, Abdullah G Al-Sehemi, Rahime Şimşek, Nouf Abubakr Babteen, Heba Alshater
Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations. PloS one 18 (2) (2023)
Muhammad Babar Taj, Ahmad Raheel, Rabia Ayub, Afnan M Alnajeebi, Matokah Abualnaja, Alaa Hamed Habib, Walla Alelwani, Sadia Noor, Sami Ullah, Abdullah G Al-Sehemi, Rahime Şimşek, Nouf Abubakr Babteen, Heba Alshater
Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations. PloS one 18 (2) (2023)
Muhammad Babar Taj, Ahmad Raheel, Rabia Ayub, Afnan M Alnajeebi, Matokah Abualnaja, Alaa Hamed Habib, Walla Alelwani, Sadia Noor, Sami Ullah, Abdullah G Al-Sehemi, Rahime Şimşek, Nouf Abubakr Babteen, Heba Alshater
Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations. PloS one 18 (2) (2023)
Muhammad Babar Taj, Ahmad Raheel, Rabia Ayub, Afnan M Alnajeebi, Matokah Abualnaja, Alaa Hamed Habib, Walla Alelwani, Sadia Noor, Sami Ullah, Abdullah G Al-Sehemi, Rahime Şimşek, Nouf Abubakr Babteen, Heba Alshater
Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations. PloS one 18 (2) (2023)
Sema Öztürk Yıldırım, Mehmet Akkurt, Gökalp Çetin, Rahime Şimşek, Raymond John Butcher, Ajaya Bhattarai
Crystal structure and Hirshfeld surface analysis of isopropyl 4-[2-fluoro-5-(tri-fluoro-meth-yl)phen-yl]-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate. Acta crystallographica. Section E, Crystallographic communications 79 (Pt 3) (2023)
Sema Öztürk Yıldırım, Mehmet Akkurt, Gökalp Çetin, Rahime Şimşek, Raymond John Butcher, Ajaya Bhattarai
Crystal structure and Hirshfeld surface analysis of isopropyl 4-[2-fluoro-5-(tri-fluoro-meth-yl)phen-yl]-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexa-hydro-quinoline-3-carboxyl-ate. Acta crystallographica. Section E, Crystallographic communications 79 (Pt 3) (2023)